MAPT and neurodegenerative disease: Along with the development of ultrahigh-sensitivity assay technologies, such as multiplexed flowmetric analysis and single-molecule array, peripheral blood samples might provide an indirect and precise detection of Aβ1-40, Aβ1-42, and tau protein depositions in the brain for prevalent neurodegenerative diseases [90,91,92].